Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Gross Profit: 2009-2024

Historic Gross Profit for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to $15.0 million.

  • Cytokinetics' Gross Profit rose 318.14% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 2549.39%. This contributed to the annual value of $15.0 million for FY2024, which is 99.20% up from last year.
  • According to the latest figures from FY2024, Cytokinetics' Gross Profit is $15.0 million, which was up 99.20% from $7.5 million recorded in FY2023.
  • In the past 5 years, Cytokinetics' Gross Profit ranged from a high of $94.6 million in FY2022 and a low of $7.5 million during FY2023.
  • For the 3-year period, Cytokinetics' Gross Profit averaged around $39.0 million, with its median value being $15.0 million (2024).
  • In the last 5 years, Cytokinetics' Gross Profit crashed by 92.04% in 2023 and then spiked by 99.20% in 2024.
  • Cytokinetics' Gross Profit (Yearly) stood at $36.5 million in 2020, then spiked by 50.41% to $54.9 million in 2021, then surged by 72.29% to $94.6 million in 2022, then plummeted by 92.04% to $7.5 million in 2023, then soared by 99.20% to $15.0 million in 2024.